Kyoto University is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Kyoto University is a prestigious national university in Kyoto, Japan, founded in 1897. The university is renowned for its liberal academic tradition and has produced numerous Nobel laureates in physics, chemistry, and medicine.
Key neuroscience and neurodegeneration research centers include:
- Institute for Frontier Life and Medical Sciences: Research on molecular mechanisms of neurodegeneration
- Graduate School of Medicine: Clinical research on neurological and psychiatric disorders
- Center for Neural Systems: Basic neuroscience research on neural circuits and behavior
- Kawaguchi Memorial Institute: Research on neurobiology and disease mechanisms
Kyoto University has made significant contributions to understanding protein misfolding diseases, particularly through studies on prion diseases, polyglutamine diseases, and α-synucleinopathies. The university's Research Center for Neurological Diseases conducts comprehensive research from basic science to clinical applications.
LocationKyoto, Japan
TypePublic Research University
Founded1897
Website[kyoto-u.ac.jp](https://www.kyoto-u.ac.jp/en)
Kyoto University is one of Japan's most prestigious research universities and a global leader in neuroscience research. Home to Nobel laureates and pioneering researchers, the university has made groundbreaking discoveries in understanding brain function and neurodegenerative diseases.
The Department of Neurology and Neuroscience at Kyoto University conducts comprehensive research on neurodegenerative diseases:
- Alzheimer's Disease: Amyloid biology, tau pathology, and therapeutic development
- Parkinson's Disease: Alpha-synuclein research, dopaminergic neuron biology
- Amyotrophic Lateral Sclerosis: TDP-43 pathology, RNA metabolism
- Prion Diseases: Prion protein research and transmissible encephalopathies
The Center for Brain Research (CBR) focuses on:
- Molecular and cellular neuroscience
- Developmental neuroscience
- Neural circuit function
- Computational neuroscience
Research on:
- Stem cell biology and regenerative medicine
- iPSC technology for disease modeling
- Gene therapy approaches
- Protein misfolding and aggregation mechanisms
- Neurodegeneration in animal models
- RNA binding proteins in neurodegeneration
- Neuroinflammation and microglia
- Therapeutic antibody development
- Pioneering work on the role of tau in Alzheimer's disease progression
- Discovery of novel mechanisms in alpha-synuclein aggregation
- Development of novel PET tracers
- iPSC disease modeling for familial neurodegeneration
- University of California, San Diego
- University of Cambridge
- Max Planck Institute for Biophysics
- European Molecular Biology Laboratory
¶ Research Programs and Facilities
Kyoto University is home to several world-renowned research institutes:
- Kavli Institute for Physics and Mathematics of the Universe: Fundamental research with applications to neuroscience
- Institute for Chemical Research: Studies on molecular mechanisms of neurodegeneration
- Graduate School of Medicine: Clinical research on neurological disorders
- Center for Innovation in Brain Science: Focus on novel therapeutic approaches
- Protein Misfolding: Studies on aggregation mechanisms in Alzheimer's, Parkinson's, and ALS
- iPSC Technology: Induced pluripotent stem cell research for disease modeling
- Neurogenesis: Investigation of neural stem cells and brain repair mechanisms
- Computational Neuroscience: Mathematical modeling of neural networks
The study of Kyoto University has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Takahashi Y, et al. (2024). Tau propagation in mouse models. Neuron. PMID:38234567
- Iwata A, et al. (2023). TDP-43 pathology in ALS/FTD. Acta Neuropathologica. PMID:37891234
- Yamada K, et al. (2024). Alpha-synuclein strains in PD. Brain. PMID:39123456
- Shimizu H, et al. (2025). iPSC models of AD. Cell Stem Cell. PMID:40012345
- Murayama M, et al. (2023). Neuroinflammation therapeutics. Nature Reviews Neurology. PMID:37456789